International Journal of Clinical Medicine
Vol.6 No.9(2015), Paper ID 59667, 9
pages
DOI:10.4236/ijcm.2015.69087
Hemoglobin Level Stability after a Switch from Darbepoetin Alfa to Epoetin Beta Pegol for the Treatment of Renal Anemia in Hemodialysis Patients
Sayaka Takahashi, Yoshiko Tanaka, Mari Takano, Keiko Suzuki, Mio Ueda, Yukiko Shimamoto, Kosaku Nitta
Department of Nephrology, Shinjuku Ishikawa Clinic, Tokyo, Japan
Department of Nephrology, Shinjuku Ishikawa Clinic, Tokyo, Japan
Department of Nephrology, Shinjuku Ishikawa Clinic, Tokyo, Japan
Department of Nephrology, Shinjuku Ishikawa Clinic, Tokyo, Japan
Department of Nephrology, Shinjuku Ishikawa Clinic, Tokyo, Japan
Department of Nephrology, Shinjuku Ishikawa Clinic, Tokyo, Japan
Department of Medicine, Kidney Center, Tokyo Women’s Medical University, Tokyo, Japan
Copyright © 2015 Sayaka Takahashi, Yoshiko Tanaka, Mari Takano, Keiko Suzuki, Mio Ueda, Yukiko Shimamoto, Kosaku Nitta et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Takahashi, S. , Tanaka, Y. , Takano, M. , Suzuki, K. , Ueda, M. , Shimamoto, Y. and Nitta, K. (2015) Hemoglobin Level Stability after a Switch from Darbepoetin Alfa to Epoetin Beta Pegol for the Treatment of Renal Anemia in Hemodialysis Patients.
International Journal of Clinical Medicine,
6, 652-660. doi:
10.4236/ijcm.2015.69087.